{
  "case_id": "case_0035",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 40.93,
    "sex": "Male",
    "genderIdentity": "Cisgender Female",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left pons.",
      "structured_data": {
        "gt_lesions_english": [
          "left pons"
        ],
        "ft_lesions_parsed": [
          {
            "location": "pons",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left pons"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- Neurosarcoid, Intracerebral Haemorrhage, Brainstem Tumour (Primary or Metastatic), Cavernous Malformation and Brainstem Infarct / Vertebral Artery Dissection.\n\nOther possible differentials:\n- NMOSD (AQP4+), MOGAD, SLE, Neurosyphilis and Listeria.\n- Also feasible but of low probability: TB, Beh\u00e7et's, Lyme, Leptomeningeal carcinomatosis, Vasculitis, Lymphoma and Brainstem Abscess.\n\nOther considerations not mentioned:\n- The presenting complaint may be distinct from the neurological signs and due to something like Gastrooesophageal reflux disease (GORD), if the signs are chronic.",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple sclerosis with left pontine demyelinating plaque",
          "Left pontine ischaemic stroke (vertebrobasilar territory)",
          "Left pontine cavernous malformation with recent haemorrhage",
          "Intrinsic pontine glioma (brainstem astrocytoma)",
          "Neurosarcoidosis involving the pons"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Gastrooesophageal reflux disease (GORD)": "incidental_cause"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [
          "Gastrooesophageal reflux disease (GORD)"
        ],
        "matched_lesion_dx_keys": [
          "Brain_Haemorrhage",
          "Brainstem_Tumour",
          "Neurosarcoidosis",
          "Cavernous_Malformation",
          "MS",
          "Brain_Infarct_Brainstem"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Tuberculosis",
          "Behcet_Disease",
          "Infection_Lyme",
          "Leptomeningeal_Carcinomatosis",
          "Syphilis",
          "Listeria_Rhombencephalitis",
          "AQP4_NMOSD",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_SLE",
          "CNS_Lymphoma",
          "MOGAD",
          "Brain_Abscess_Brainstem"
        ],
        "missing_common_names": [
          "Neurosyphilis",
          "Listeria",
          "NMOSD (AQP4+)",
          "SLE",
          "MOGAD"
        ],
        "missing_low_prob_names": [
          "TB",
          "Beh\u00e7et's",
          "Lyme",
          "Leptomeningeal carcinomatosis",
          "Vasculitis",
          "Lymphoma",
          "Brainstem Abscess"
        ],
        "additional_diagnoses": []
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 2,
        "gt_matched_count": 1,
        "gt_missed_count": 1,
        "gt_coverage_percentage": 0.5,
        "additional_less_plausible_count": 0,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 1,
        "lesion_ddx_total_count": 18,
        "lesion_ddx_matched_count": 6,
        "lesion_ddx_missed_common_count": 5,
        "lesion_ddx_missed_low_prob_count": 7,
        "lesion_ddx_coverage_percentage": 0.3333333333333333
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, anti-AQP4, ENA, ACE, HIV, ANCA, syphilis, ESR.\n- Could also consider testing: anti-dsDNA, TB, lyme, CSF (flow cytometry, PCR for Listeria and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain with brainstem protocol and gadolinium",
          "MRI of cervical spine with gadolinium",
          "Magnetic resonance angiography of head and neck",
          "Non-contrast CT Brain",
          "Lumbar puncture with cerebrospinal fluid analysis (cell count, protein, glucose, oligoclonal bands)",
          "Visual evoked potentials",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Lipid profile",
          "HbA1c",
          "Coagulation screen",
          "Thyroid function tests",
          "Serum vitamin B12 level",
          "Serum folate level",
          "Serum angiotensin-converting enzyme level",
          "Antinuclear antibody",
          "Extractable nuclear antigen antibody panel",
          "Antineutrophil cytoplasmic antibodies",
          "HIV antibody/antigen test",
          "Syphilis serology",
          "Aquaporin-4 antibody",
          "Myelin oligodendrocyte glycoprotein antibody",
          "Electrocardiogram",
          "Transthoracic echocardiogram",
          "24-hour ambulatory ECG monitoring"
        ],
        "all_identified_ft_keys": [
          "Lipid_Profile",
          "MOG_Antibodies",
          "CRP",
          "TFT",
          "Coagulation_Screen",
          "ENA_Panel",
          "LFT",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ECG",
          "CSF_General",
          "FBC",
          "ANA",
          "MRI_Cervical_Spine",
          "Folate",
          "ANCA",
          "HIV_Test",
          "MRA_Head_Neck",
          "VEP",
          "MRI_Brain",
          "ESR",
          "CT_Head"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "CSF_Listeria_PCR",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "CSF_Listeria_PCR",
          "TB_Screen",
          "CSF_Cytology",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 2,
        "primary_tests_found_count": 2,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 10,
        "ddx_tests_coverage_percentage": 0.625
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to suggest treatment at this time.\n  \nCorrectly identified the following:\n\n- Presenting complaint is not necessarily a symptom of MS so indication for steroids is unclear.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Admission to a neurology or stroke unit with close neurological observation",
            "timing": "Start Now",
            "reasons": [
              "Brainstem lesions can deteriorate rapidly affecting consciousness, breathing and swallowing",
              "Allows frequent neurological observations and rapid access to imaging and specialist input"
            ]
          },
          {
            "treatment": "Swallow assessment and nil-by-mouth until assessed",
            "timing": "Start Now",
            "reasons": [
              "Brainstem involvement increases risk of silent aspiration even if speech and palate appear normal",
              "Early swallow assessment reduces pneumonia risk and guides safe route for nutrition and medications"
            ]
          },
          {
            "treatment": "Intermittent pneumatic compression devices for venous thromboembolism prophylaxis",
            "timing": "Start Now",
            "reasons": [
              "Hemiparesis and reduced mobility increase risk of deep vein thrombosis",
              "Mechanical prophylaxis is safe before intracranial haemorrhage has been excluded"
            ]
          },
          {
            "treatment": "Physiotherapy, occupational therapy and early neurorehabilitation",
            "timing": "Start Now",
            "reasons": [
              "Early mobilisation and task-specific therapy improve functional recovery after focal brain lesions",
              "Helps prevent contractures, deconditioning and falls related to ataxia and weakness"
            ]
          },
          {
            "treatment": "Proton pump inhibitor therapy for gastro-oesophageal reflux symptoms",
            "timing": "Start Now",
            "reasons": [
              "Patient\u2019s presenting heartburn and acid taste are symptomatic and easily treatable",
              "Reducing reflux may lessen aspiration risk if swallowing becomes impaired"
            ]
          },
          {
            "treatment": "Pharmacologic venous thromboembolism prophylaxis with low-molecular-weight heparin",
            "timing": "Delay",
            "reasons": [
              "Anticoagulation could worsen an unrecognised brainstem haemorrhage or bleeding cavernoma",
              "Should be started only after MRI/CT has excluded haemorrhage and neurosurgical lesions"
            ]
          },
          {
            "treatment": "Aspirin 300 mg daily followed by 75 mg daily",
            "timing": "Delay",
            "reasons": [
              "If imaging confirms an ischaemic pontine stroke, early antiplatelet therapy reduces recurrence risk",
              "Must be delayed until intracranial haemorrhage, cavernoma with recent bleed or major tumour are excluded on imaging"
            ]
          },
          {
            "treatment": "High-intensity statin therapy (e.g., atorvastatin 80 mg nightly)",
            "timing": "Delay",
            "reasons": [
              "Indicated for secondary prevention if ischaemic stroke is confirmed",
              "Should follow confirmation of vascular aetiology and baseline liver function testing"
            ]
          },
          {
            "treatment": "High-dose intravenous methylprednisolone for 3\u20135 days",
            "timing": "Delay",
            "reasons": [
              "Shortens relapse duration in an acute demyelinating brainstem lesion such as multiple sclerosis",
              "Should only be commenced once MRI/CSF strongly support demyelination and active infection has been excluded"
            ]
          },
          {
            "treatment": "Long-term disease-modifying therapy for multiple sclerosis",
            "timing": "Delay",
            "reasons": [
              "Requires definite diagnosis of multiple sclerosis based on clinical and radiological criteria",
              "Choice of agent depends on disease activity, comorbidities and patient preference and is not an emergency decision"
            ]
          },
          {
            "treatment": "Neurosurgical or radiosurgical consultation for cavernous malformation or intrinsic pontine tumour if identified",
            "timing": "Delay",
            "reasons": [
              "Surgical or radiosurgical management depends on precise imaging diagnosis and risk\u2013benefit assessment",
              "Intervention is usually elective unless there is life-threatening mass effect or repeated haemorrhage"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone for 3\u20135 days",
            "timing": "Delay",
            "reasons": [
              "Shortens relapse duration in an acute demyelinating brainstem lesion such as multiple sclerosis",
              "Should only be commenced once MRI/CSF strongly support demyelination and active infection has been excluded"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": [
                "Presenting complaint is not necessarily a symptom of MS so indication for steroids is unclear."
              ]
            }
          },
          "evaluation_summary": "Not appropriate to suggest treatment at this time.\n  \nCorrectly identified the following:\n\n- Presenting complaint is not necessarily a symptom of MS so indication for steroids is unclear.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Long-term disease-modifying therapy for multiple sclerosis",
            "timing": "Delay",
            "reasons": [
              "Requires definite diagnosis of multiple sclerosis based on clinical and radiological criteria",
              "Choice of agent depends on disease activity, comorbidities and patient preference and is not an emergency decision"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 2,
          "reasons_acknowledged": 2,
          "reasons_missed": 0,
          "reasons_coverage_percentage": 1.0
        }
      }
    }
  }
}